相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
Tristan T. Sands et al.
CNS DRUGS (2019)
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
Orrin Devinsky et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cannabis for the Treatment of Epilepsy: an Update
Tyler E. Gaston et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Inhibitory effects of cannabidiol on voltage-dependent sodium currents
Mohammad-Reza Ghovanloo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
Luciano R. Vilela et al.
EPILEPSY & BEHAVIOR (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Medical Cannabinoids in Children and Adolescents: A Systematic Review
Shane Shucheng Wong et al.
PEDIATRICS (2017)
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
Adam P. Ostendorf et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
Rongrong Jiang et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
A National Profile of Childhood Epilepsy and Seizure Disorder
Shirley A. Russ et al.
PEDIATRICS (2012)
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
Satoshi Yamaori et al.
LIFE SCIENCES (2011)
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Mateus Machado Bergamaschi et al.
CURRENT DRUG SAFETY (2011)
Inhibition of recombinant human T-type calcium channels by Δ9-Tetrahydrocannabinol and cannabidiol
Hamish Redmond Ross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
